A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition
暂无分享,去创建一个
[1] V. Eusebi,et al. Endocrine differentiation in mucoid carcinoma of the breast , 1980, Histopathology.
[2] K. Czene,et al. Incidence and prognosis of synchronous and metachronous bilateral breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Delatorre,et al. Inflammatory carcinoma of the breast , 1971 .
[4] M. Bilous. Breast core needle biopsy: issues and controversies , 2010, Modern Pathology.
[5] Rohit Bhargava,et al. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation , 2010, Modern Pathology.
[6] D. Visscher,et al. Clinicopathologic Analysis of Solid Papillary Carcinoma of the Breast and Associated Invasive Carcinomas , 2006, The American journal of surgical pathology.
[7] Sunil R. Lakhani,et al. WHO classification of tumours of the breast , 2012 .
[8] W. Dupont,et al. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma , 1996, Cancer.
[9] E. López-Bonet,et al. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling. , 2008, Oncology reports.
[10] H. Kang,et al. Metaplastic breast cancer: clinicopathological features and its prognosis , 2012, Journal of Clinical Pathology.
[11] I. Yeh,et al. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. , 2005, American journal of clinical pathology.
[12] K. Hunt,et al. Invasive neuroendocrine carcinoma of the breast , 2010, Cancer.
[13] M. Prasad,et al. Microinvasive carcinoma (T1mic) of the breast: clinicopathologic profile of 21 cases. , 2000, The American journal of surgical pathology.
[14] Peter Devilee,et al. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .
[15] Magali Lacroix-Triki,et al. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type , 2010, The Journal of pathology.
[16] J. Peterse,et al. Refinement of breast cancer classification by molecular characterization of histological special types , 2008, The Journal of pathology.
[17] York Springer,et al. Ajcc Cancer Staging Manual. 7th Ed. New , 2010 .
[18] J. Reis-Filho,et al. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple‐negative and basal‐like breast cancers , 2012, The Journal of pathology.
[19] M. Kimmel,et al. Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. , 1990, American journal of clinical pathology.
[20] R. J. Rosser. Consensus conference on the classification of ductal carcinoma in Situ , 1998, Cancer.
[21] as named below. Consensus Conference on the Classification of Ductal Carcinoma In Situ , 1997, Human pathology.
[22] Lajos Pusztai,et al. A clinically relevant gene signature in triple negative and basal-like breast cancer , 2010, Breast Cancer Research.
[23] T. Akiyama,et al. :A long term follow-up study , 1982 .
[24] I. Ellis,et al. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. , 2009, European journal of cancer.
[25] W. Dupont,et al. Atypical hyperplastic lesions of the female breast: A long-term follow-up study , 1986 .
[26] T. Krausz,et al. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential. , 2010, Seminars in diagnostic pathology.
[27] G. Azabdaftari,et al. Refinement of breast cancer classification by molecular characterization of histological special types , 2009 .
[28] D. Henson,et al. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. , 1998, Archives of pathology & laboratory medicine.
[29] A. Gown,et al. Intracystic Papillary Carcinomas of the Breast: A Reevaluation Using a Panel of Myoepithelial Cell Markers , 2006, The American journal of surgical pathology.
[30] M. Jensen,et al. Invasive lobular breast cancer. Prognostic significance of histological malignancy grading , 2007, Acta oncologica.
[31] S. Toikkanen,et al. Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up. , 1989, Human pathology.
[32] L. Middleton. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type: Lacroix-Triki M, Suarez PH, Mackay A, et al (Inst of Cancer Res, London, UK; et al) J Pathol 222:282-298, 2010 , 2011 .
[33] Xin-min Zhang,et al. Breast Carcinoma With Micropapillary Features: Clinicopathologic Study and Long-Term Follow-Up of 100 Cases , 2008, International journal of surgical pathology.
[34] A. Luini,et al. Clinicopathologic characteristics of invasive lobular carcinoma of the breast , 2008, Cancer.
[35] I. Ellis,et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma , 2002, Histopathology.
[36] O. Olopade,et al. Concordance in histological and biological parameters between first and second primary breast cancers , 2011, Cancer.
[37] J. Siegel. Inflammatory carcinoma of the breast. , 1952, A.M.A. archives of dermatology and syphilology.